USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: XERIS PHARMACEUTICALS, INC.
City: Austin
State: TX
Zip+4: 78705-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $500,602.00 2
SBIR Phase II $994,123.00 1

Award List:

IMPROVED HYPOGLYCEMIA RESCUE DEVICE

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: John Kinzell
Award Amount: $157,478.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this program is to develop of a clinical prototype, semi-solid drug formulation and auto-injector pen that deliver microliter volumes of a glucagon dose without reconstitution for hypoglycemic emergenci es. To assess the feasibility of this… More

Improved Hypoglycemia Rescue Device

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: John Kinzell – 415-472-4623
Award Amount: $994,123.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this project is to demonstrate the safety, pharmacokinetics and initial efficacy of a ready-to-use Glucagon Rescue Pen that will deliver a very low volume dose of a glucagon without reconstitution for hypoglycemic emergencies. To execute on this… More

Clinical Development of a Stable Glucagon Formulation for Bi-hormonal Pump

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Steven Prestrelski – 510-742-9700
Award Amount: $343,124.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this program is to further the development of a novel, stable, non-aqueous glucagon formulation as an integral component of a bi-hormonal (insulin-glucagon) pump system for treatment of persons with diabetes. The addition of glucagon to the… More